Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Financial Reports: Abbott 1Q



Published April 18, 2012
Related Searches: Pharma • Financial Reports •
1Q Revenues: $9.4 billion (+4%)

1Q Earnings: $1.2 billion (+44%)

Comments: Proprietary pharma revenues were up 7% to $4.1 billion, driven by Humira (+17% to $1.9 billion). The established pharma revenues (ex-U.S.) was down 2% to $1.3 billion.


Related Online Exclusives
blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: